U.S. markets open in 1 hour 32 minutes
  • S&P Futures

    3,885.50
    +18.00 (+0.47%)
     
  • Dow Futures

    31,532.00
    +174.00 (+0.55%)
     
  • Nasdaq Futures

    13,119.50
    +64.25 (+0.49%)
     
  • Russell 2000 Futures

    2,252.30
    +23.20 (+1.04%)
     
  • Crude Oil

    60.59
    +0.84 (+1.41%)
     
  • Gold

    1,723.70
    -9.90 (-0.57%)
     
  • Silver

    26.66
    -0.22 (-0.81%)
     
  • EUR/USD

    1.2066
    -0.0022 (-0.18%)
     
  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     
  • Vix

    23.20
    -0.15 (-0.64%)
     
  • GBP/USD

    1.3963
    +0.0007 (+0.05%)
     
  • USD/JPY

    106.9130
    +0.2030 (+0.19%)
     
  • BTC-USD

    52,307.61
    +3,316.04 (+6.77%)
     
  • CMC Crypto 200

    1,045.48
    +57.39 (+5.81%)
     
  • FTSE 100

    6,664.51
    +50.76 (+0.77%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

U.S. FDA approves RedHill's H. pylori infection treatment

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Nov 4 (Reuters) - The U.S. Food and Drug Administration has approved RedHill Biopharma Ltd's drug to treat infections caused by bacteria known as Helicobacter pylori, the Israel-based company said on Monday.

RedHill expects to launch the drug, Talicia, in the United States in the first quarter next year.

Helicobacter pylori infection affects over 50% of the population worldwide, according to Redhill, and is one of the strongest risk factor for the development of gastric cancer. (Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)